Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy

By sjmartinez • February 22, 2024

Nevarez-Mejia J, Jin YP, Pickering H, Parmar R, Valenzuela NM, Sosa RA, Heidt S, Fishbein GA, Rozengurt E, Baldwin WM 3rd, Fairchild RL, Reed EF. Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy. Am J Transplant. 2023 Oct 29:S1600-6135(23)00822-5. doi: 10.1016/j.ajt.2023.10.020. Epub ahead of print. PMID: 38379280.

Tags: AMR, antibody-mediated rejection, AOIs, areas of interest, cardiac allograft vasculopathy, CAV, Digestive Diseases, donor-specific HLA antibodies, DSA, EC, endothelial cell, HLA, human leukocyte antigen, Publications, transplant vasculopathy, TV

Cost effectiveness of hepatitis C direct acting agents

Shetty A, Lee M, Valenzuela J, Saab S. Cost effectiveness of hepatitis C direct acting agents. Expert Rev Pharmacoecon Outcomes Res. 2024 Apr 26. doi:[...]

Diet and the gut microbiome in patients with Parkinson’s disease

Kwon D, Zhang K, Paul KC, Folle AD, Del Rosario I, Jacobs JP, Keener AM, Bronstein JM, Ritz B. Diet and the gut microbiome in[...]

Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota

Andréasson K, Olofsson T, Lagishetty V, Alrawi Z, Klaassens E, Holster S, Hesselstrand R, Jacobs JP, Wallman JK, Volkmann ER. Treatment for Rheumatoid Arthritis Associated[...]